Progress in oral therapy of diabetes mellitus with sulphonylureas of the second generation.
D000328:Adult; D000367:Age Factors; D000818:Animals; D002417:Cattle; D002747:Chlorpropamide / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D005905:Glyburide / Q000627:therapeutic use; D006801:Humans; D007328:Insulin / Q000378:metabolism / Q000627:therapeutic use; D000078790:Insulin Secretion; D010179:Pancreas / Q000187:drug effects; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*; D014044:Tolbutamide / Q000627:therapeutic use; D014970:Xanthines / Q000627:therapeutic use
D007328:Insulin; D013453:Sulfonylurea Compounds; D014970:Xanthines; D014044:Tolbutamide; D005905:Glyburide; D002747:Chlorpropamide